摩拉联合扩血管药物治疗突发性耳聋的临床观察

Therapeutic effect of Mora combined with vasodilators for sudden hearing loss

目的探讨摩拉联合扩血管药物治疗突发性耳聋的疗效。方法选取2013年10月~2016年10月120例(128耳)突发性耳聋患者为研究对象,将所有患者按入院时间随机分为两组,A组患者60例(66耳)给予摩拉治疗以及改善微循环、糖皮质激素及营养神经等综合治疗12 d;B组患者60例(62耳)单纯给予改善微循环、糖皮质激素及营养神经等综合治疗12 d。观察两组治疗情况。结果 A组的治疗总有效率为90.91%,高于B组的74.19%,经比较且差异具有统计学意义(P<0.05)。结论摩拉联合扩血管药物治疗突发性耳聋,能够显著提高临床疗效,且无毒副作用,值得应用推广。

Objective To investigate the therapeutic effect of Mora combined with vasodilators for sudden hearing loss. Methods 120 patients （ 128 ears） suffering from sudden hearing loss and hospitalized in our department from Oct 2013 to Oct 2016 were included. According to the admission time, all the patients were randomly divided into two groups. 60 cases （66 ears） in group A received treatment of Mora combined with vasodilators, glucocorticoids and neurotrophic drugs. 60 eases （62 ears） in group B were treated by using vasodilators, glucocorticoids and neurotrophic drugs. The treatment course was 12 days for both groups. Their therapeutic effects were observed and compared. Results The total effective rate of group A was 90.91%, which was higher than that of group B （74.19%）. The difference of total effective rate between both groups was statistically significant （ P 〈 0.05 ）. Conclusion Mora combined with vasodilators can significantly improve the therapeutic effect without any side effect which is worth applying and recommending in the treatment of sudden hearing loss.